Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study

被引：0
作者：
Michela Del Prete
François-Alexandre Buteau
Jean-Mathieu Beauregard
机构：
[1] Université Laval,Department of Radiology and Nuclear Medicine, and Cancer Research Center
[2] CHU de Québec – Université Laval,Department of Medical Imaging, and Oncology Branch of Research Center
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2017年 / 44卷
关键词：
Personalized; Peptide receptor radionuclide therapy; Lu-octreotate; Dosimetry; Neuroendocrine tumours;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1490 / 1500
页数：10
相关论文
共 50 条
[21]   Peptide receptor radionuclide therapy with 177Lu-DOTA-octreotate: dosimetry, nephrotoxicity, and the effect of hematological toxicity on survival [J].
Loeser, Anastassia ;
Schwarzenboeck, Sarah M. ;
Heuschkel, Martin ;
Willenberg, Holger S. ;
Krause, Bernd J. ;
Kurth, Jens .
NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (03) :236-246
[22]   Peptide receptor radionuclide therapy for neuroendocrine tumours [J].
Siraj Yusuf ;
Shahad Alsadik ;
Adil AL-Nahhas .
Clinical and Translational Imaging, 2018, 6 :101-111
[23]   Peptide receptor radionuclide therapy of neuroendocrine tumours [J].
Bodei, L. ;
Giammarile, F. .
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2009, 33 (03) :142-147
[24]   Peptide receptor radionuclide therapy of neuroendocrine tumours [J].
Brabander, Tessa ;
Teunissen, Jaap J. M. ;
Van Eijck, Casper H. J. ;
Franssen, Gaston J. H. ;
Feelders, Richard A. ;
de Herder, Wouter W. ;
Kwekkeboom, Dik J. .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 30 (01) :103-114
[25]   Peptide receptor radionuclide therapy for neuroendocrine tumours [J].
Yusuf, Siraj ;
Alsadik, Shahad ;
Al-Nahhas, Adil .
CLINICAL AND TRANSLATIONAL IMAGING, 2018, 6 (02) :101-111
[26]   Personalized kidney dosimetry in 177Lu-octreotate treatment of neuroendocrine tumours: a comparison of kidney dosimetry estimates based on a whole organ and small volume segmentations [J].
Hou, Xinchi ;
Zhao, Wei ;
Beauregard, Jean-Mathieu ;
Celler, Anna .
PHYSICS IN MEDICINE AND BIOLOGY, 2019, 64 (17)
[27]   177Lu-DOTATATE Peptide Receptor Radionuclide Therapy: Dose Response in Small Intestinal Neuroendocrine Tumors [J].
Jahn, Ulrika ;
Ilan, Ezgi ;
Sandstrom, Mattias ;
Garske-Roman, Ulrike ;
Lubberink, Mark ;
Sundin, Anders .
NEUROENDOCRINOLOGY, 2020, 110 (7-8) :662-670
[28]   Safety of multiple repeated cycles of 177Lu-octreotate in patients with recurrent neuroendocrine tumour [J].
Anna Yordanova ;
Karin Mayer ;
Peter Brossart ;
Maria A. Gonzalez-Carmona ;
Christian P. Strassburg ;
Markus Essler ;
Hojjat Ahmadzadehfar .
European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 :1207-1214
[29]   Peptide Receptor Radionuclide Therapy in Rectal Neuroendocrine Tumours [J].
Tham, W. Y. A. ;
Huang, H. L. ;
Tai, W. M. D. ;
Yan, X. S. ;
Ng, C. E. D. ;
Loke, S. H. K. .
NEUROENDOCRINOLOGY, 2020, 110 :275-275
[30]   Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study [J].
Bodei, Lisa ;
Cremonesi, Marta ;
Grana, Chiara M. ;
Fazio, Nicola ;
Iodice, Simona ;
Baio, Silvia M. ;
Bartolomei, Mirco ;
Lombardo, Dario ;
Ferrari, Mahila E. ;
Sansovini, Maddalena ;
Chinol, Marco ;
Paganelli, Giovanni .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (12) :2125-2135
12345